[{"data":1,"prerenderedAt":64},["ShallowReactive",2],{"q-nurse-110-2-psychiatric-community-029":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":33,"lastmod":63},"精神科與社區衛生護理學","psychiatric-community",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-110-2-精神科與社區衛生護理學-029","nurse-110-2-psychiatric-community-029",110,2,29,"美沙冬（Methadone）本為麻醉性止痛劑，可替代嗎啡類藥物，以達到治療嗎啡類藥物成癮患者。下列敘述何者正確？",{"A":14,"B":15,"C":16,"D":17},"通常用來治療 K 他命成癮的患者","不會有蓄積性，可長期使用，且不需減少劑量","不會有呼吸抑制、欣快感和戒斷症狀","為口服藥劑，可以減少因共用針頭引起的疾病感染","D",null,[],"本題考點在美沙冬(Methadone)替代療法的特性。依藥理與治療設計，美沙冬為長效口服鴉片類製劑，用於海洛因等嗎啡類成癮者的替代維持治療，口服給藥可避免注射與共用針頭導致的感染(如HIV、C型肝炎)傳播，故選D正確。A美沙冬用於嗎啡\u002F海洛因類成癮，並非治療K他命成癮；B美沙冬具蓄積性、半衰期長，需依個別狀況調整並逐步減量，說「無蓄積、不需減量」錯誤;C美沙冬本身仍是鴉片類，過量會呼吸抑制，也會產生欣快感與戒斷症狀，說「不會有」與其藥理不符，皆錯誤。","美沙冬是長效μ鴉片受體致效劑，替代維持療法透過穩定占據受體、減少渴求與戒斷，並以口服取代注射降低血液傳染病風險。仍具鴉片類共同風險：呼吸抑制、依賴、戒斷、半衰期長易蓄積過量。減害(harm reduction)是核心理念。口訣「口服長效替海洛因」。可連結：鴉片受體、替代療法、減害策略、Buprenorphine比較。",[24,27,29,31],{"term":25,"count":26},"美沙冬",1,{"term":28,"count":26},"鴉片替代療法",{"term":30,"count":26},"減害策略",{"term":32,"count":26},"鴉片受體",[34,38,43,47,53,58],{"webId":35,"stem":36,"number":37,"year":9,"session":10},"nurse-110-2-psychiatric-community-030","有關護理評估自閉症類群障礙症（autism spectrum disorder）的核心障礙，下列何者錯誤？",30,{"webId":39,"stem":40,"number":41,"year":42,"session":26},"nurse-111-1-psychiatric-community-046","某護理師欲探討罕見病例的危險因子，下列何種研究方法最適當？",46,111,{"webId":44,"stem":45,"number":46,"year":42,"session":10},"nurse-111-2-psychiatric-community-060","下列何者最適合用來解釋嚴重特殊傳染性肺炎（COVID-19）的致病模式？",60,{"webId":48,"stem":49,"number":50,"year":51,"session":52},"nurse-112-3-psychiatric-community-018","葉先生，36 歲，診斷恐慌症，發作時感到喘不過氣、胸痛、四肢麻痺，在急診時大喊：「我覺得快死了！」，下列護理師的處置，何者最適宜？",18,112,3,{"webId":54,"stem":55,"number":56,"year":57,"session":26},"nurse-114-1-psychiatric-community-022","對於安置在精神護理之家的病人，下列服務內容何者最適宜？",22,114,{"webId":59,"stem":60,"number":61,"year":62,"session":10},"nurse-115-2-psychiatric-community-016","有關身體症狀障礙症（somatic symptom disorder）的敘述，下列何者最適當？",16,115,"2026-09-04",1788510730743]